Home › NDC Lookup › RxCUI directory › RxCUI 1592748

Nintedanib 100 MG Oral Capsule [Ofev] — RxCUI 1592748

RxNorm drug concept · Semantic branded drug
RxCUI 1592748 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1592748
Official nameNintedanib 100 MG Oral Capsule [Ofev]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asOfev 100 MG (as nintedanib ethanesulfonate 120.4 MG) Oral Capsule; Ofev 100 MG Oral Capsule
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)7,483 prescriptions · 33 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Nintedanib: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats scarring lung diseases in adults. That includes idiopathic pulmonary fibrosis and other chronic fibrosing interstitial lung diseases that keep getting worse. Some product...
  • Take them twice a day, about 12 hours apart, with food. Swallow them whole with liquid. Don't chew, open or crush them. If you miss a dose, just take the next one at the usual time...
  • Diarrhea is the big one, and nausea, vomiting, belly pain, and less appetite are common too. Tell us early about diarrhea so we can help with fluids and medicine like loperamide. C...
  • Nintedanib can affect your liver, mostly in the first three months. We check liver tests before you start, regularly early on, and periodically afterward. Call us if you notice dar...
📖 Read our full Nintedanib guide →

🕸️ Concept Web — How Nintedanib 100 MG Oral Capsule [Ofev] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Nintedanib 100 MG Oral Capsule [Ofev] RxCUI 1592748

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Nintedanib 1592737
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Ofev 1592743
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Nintedanib Oral Capsule 1592741
    • Nintedanib Oral Product 1592739
    • Nintedanib Pill 1592740
    • Nintedanib Oral Capsule [Ofev] 1592745
    • Ofev Oral Product 1592746
    • Ofev Pill 1592747
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Nintedanib 100 MG Oral Capsule SCD · 1592742
  • Nintedanib 100 MG SCDC · 1592738
  • Nintedanib Oral Capsule SCDF · 1592741
  • Nintedanib Oral Product SCDG · 1592739
  • Nintedanib Pill SCDG · 1592740

Brand-Name Concepts

  • Nintedanib 100 MG [Ofev] SBDC · 1592744
  • Nintedanib Oral Capsule [Ofev] SBDF · 1592745
  • Ofev Oral Product SBDG · 1592746
  • Ofev Pill SBDG · 1592747
  • Ofev BN · 1592743

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 1592748 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00597-0143-60 1 BOTTLE in 1 CARTON (0597-0143-60) / 60 CAPSULE in 1 BOTTL... Ofev Boehringer Ingelheim Pharmaceuticals, Inc. 2014-10-17
00597-0145-60 1 BOTTLE in 1 CARTON (0597-0145-60) / 60 CAPSULE in 1 BOTTL... Ofev Boehringer Ingelheim Pharmaceuticals, Inc. 2014-10-17
Observed labelers: Boehringer Ingelheim Pharmaceuticals, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.